Treatment Options for Patients with Non-Small Cell Lung Cancer and Liver Metastases
Vesna Ćeriman Krstić, Natalija Samardžić, Milija Gajić, Milan Savić, Biljana Šeha, Marina Roksandić Milenković, Dragana Jovanović · 2024
Read Treatment Options for Patients with Non-Small Cell Lung Cancer and Liver Metastases by Vesna Ćeriman Krstić, Natalija Samardžić, Milija Gajić, Milan Savić, Biljana Šeha, Marina Roksandić Milenković, Dragana Jovanović (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11726995.txt.
Description
Vesna Ceriman Krstic and co-authors review in a 2024 paper care options when lung cancer spreads to the liver. Non small cell lung cancer with liver spread fares worst, with survival of three to six months. Most such patients respond poorly to chemo, and immune drug results are mixed in reports.
The liver tends to tolerate foreign tissue, which may blunt immune attack on tumors there. That trait, with quieting signals, may explain weak drug response in this subgroup. Blends of therapies look like the better path for these patients, the authors argue. Adding beam therapy to immune drugs may help picked cases. Cutting out a lone liver spot is also worth weighing in the right patient.
Catalog record
| CREATOR | Vesna Ćeriman Krstić, Natalija Samardžić, Milija Gajić, Milan Savić, Biljana Šeha, Marina Roksandić Milenković, Dragana Jovanović |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |